Drug intelligence / Profile preview

68Ga-P3

Development stage: Unknown
Lead developer: Peking University First Hospital
Modality: Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptide-Drug Conjugates → Peptide Conjugates → Peptides
Administration: Intravenous

Overview

68Ga-P3 is a diagnostic radiopharmaceutical composed of a human prostate-specific membrane antigen (PSMA)-targeting ligand, P3, labeled with the radioisotope gallium-68. It is designed for positron emission tomography (PET) imaging to detect PSMA-expressing lesions, primarily in prostate cancer. The drug binds to PSMA on malignant prostate cells; the radioactive gallium-68 emits positrons that are detected by PET/CT imaging systems, allowing for sensitive and specific localization of tumors. In clinical studies, 68Ga-P3 has demonstrated high sensitivity and specificity for tumor localization and can also be used intraoperatively with fluorescence imaging to guide surgical resection. The agent was initially developed by Peking University First Hospital and is currently in clinical development for use in patients with prostate cancer[1][3].

Other names: gallium Ga 68 P3

Targets

PSMA (Prostate-specific membrane antigen)

Beyond the preview

Go deeper on 68Ga-P3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 68Ga-P3.

Explore the full profile